Disclosure Quest - Search SEC Filings

More options

Type of Offering

Amount To Be Raised

to

Filing Date

to

Type of Security

Industry

CIK Number

Principal Place Of Business

Found 5 results

Name	Type of Offering	Accepted Date
Gameto, Inc. See All Filings	D	2025-08-26 13:46:59 UTC
Amount To Be Raised $43,999,930 Associated Brokers / Dealers N/A CIK Number 0001901628 Filed Document 0001901628-25-000003 Exclusions or Exemptions 506b Accepted Date 2025-08-26 13:46:59 UTC Type of Offering D Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity
Gameto, Inc. See All Filings	D	2024-05-29 12:52:51 UTC
Amount To Be Raised $42,999,962 Associated Brokers / Dealers N/A CIK Number 0001901628 Filed Document 0001901628-24-000001 Exclusions or Exemptions 506b Accepted Date 2024-05-29 12:52:51 UTC Type of Offering D Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity
Gameto, Inc. See All Filings	D	2022-09-07 15:40:04 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers N/A CIK Number 0001901628 Filed Document 0001901628-22-000006 Exclusions or Exemptions 506b Accepted Date 2022-09-07 15:40:04 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Gameto, Inc. See All Filings	D/A	2022-09-07 15:37:14 UTC
Amount To Be Raised $26,999,944 Associated Brokers / Dealers N/A CIK Number 0001901628 Filed Document 0001901628-22-000005 Exclusions or Exemptions 506b Accepted Date 2022-09-07 15:37:14 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Gameto, Inc. See All Filings	D	2022-01-11 14:59:09 UTC
Amount To Be Raised $19,999,947 Associated Brokers / Dealers N/A CIK Number 0001901628 Filed Document 0001901628-22-000002 Exclusions or Exemptions 506b Accepted Date 2022-01-11 14:59:09 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity